The UromigosThe Uromigos | April 8, 2024
Dr. Galsky describes the OS signal data from CheckMate-274 on adjuvant nivolumab for muscle-invasive bladder cancer.
Listen Now
The UromigosThe Uromigos | April 8, 2024
Dr. Matt Galsky, Brian, and Tom discuss the IMvigor011 trial data that was presented at EAU 2024.
GU Oncology Now EditorsThe Uromigos | September 21, 2022
Betsy Plimack discusses the tricks of the trade for adverse event management.
The UromigosThe Uromigos | February 17, 2023
Dr. Ashish Kamat walks through ongoing issues around surgery in urothelial cancer at EAU 2021.
The UromigosThe Uromigos | July 20, 2021
Peter Albers talks about exciting updates in prostate cancer research and picks his three highlights from EAU21.
The UromigosThe Uromigos | July 14, 2021
Dr. Grant Stewart discusses renal cancer data presented at the 2021 EAU Conference.